Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clifutinib besylate plus chemotherapy in newly diagnosed adult acute myeloid leukemia
CTR20212464Phase 2Active
- Sponsor
- HEC Pharm
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clifutinib in acute myeloid leukemia (AML), sponsored by HEC Pharm. Started Nov 2022; status: active.
02
Drugs
clifutinib
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on CTR20212464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212464.